Prof. Arndt Rolfs MD
Chief Executive Officer
Arndt Rolfs, Professor for Neurology and Psychiatry at the
University of Rostock, Germany and head of the Albrecht-Kossel-Institute for Neuroregeneration, has been designated CEO of
CENTOGENE, effective June 1, 2014. His extensive medical and
scientific expertise will further the growth of CENTOGENE.
Arndt Rolfs received his approbation for human medicine from the Universities of Mainz and Vienna in 1985 and was granted a
tenure track professorship for clinical neurology in 1997. He worked at the Department of Neurology and as head of the
Laboratory for Neurochemistry of the Free University of Berlin, at the Max Planck Institute for Molecular Genetics, and at the
psychiatric clinic of the University Hospital Rudolf-Virchow in
Berlin. Since 1998 he has been the Head of the Neurobiological Research Laboratory and Vice-Director of the Neurological clinic and outpatients department at the University of Rostock. In 2008 he was appointed Director of the Albrecht-Kossel-Institute for Neuroregeneration at the University of Rostock.
Arndt Rolfs is a principal investigator of several international
multicenter studies in the area of rare diseases, including the Sifap project (www.sifap.eu), the world's largest study in young stroke patients related to Fabry disease, several biomarker
studies (e.g. BioGaucher, BioHunter, BioMorquio) and
epidemiological studies in neurogenetic aetiologies. He has
authored or contributed to more than 180 peer-reviewed
publications, acts as a consultant for international biotech and
industrial companies, and is also a consultant for the EMA and FDA.
Furthermore, he was co-founder of the biotech companies Arcensus AG and Genebanking.
Arndt Rolfs has been Chief Medical Director and major
shareholder of CENTOGENE since its foundation.
Prof. Peter Bauer MD
Chief Operating Officer
Peter joined CENTOGENE January 1, 2016 as Chief Operating Officer. With his extraordinary experience especially in the high-throughput genetic testing on the basis of Next-Generation Sequencing, Peter will be ideal for combining clinical and medical understanding in genetic testing with an excellent knowledge in laboratory techniques.
Peter is passionate about turning the medical questions into a complete and fast analytical process, ensuring that the medically driven result is brought back to the clinician and the patient
After studying Medicine in Freiburg and Berlin, Peter worked as a resident in Neurology in Rostock and as a resident in Human
Genetics in Tübingen since 1997. He received his board
certification in Human Genetics in 2006 and heads the molecular diagnostic laboratory at the Institute of Medical Genetics and
Applied Genomics at the University Hospital Tübingen. His
experience ranges from medium to high-throughput genetic
analyses including the application of Next-Generation Sequencing in a clinical setting, genetic research in neurodegenerative
disease and hereditary cancer.
Peter has authored more than 140 publications in neurogenetics, oncogenetics, cardiogenetics, and sequencing technology. He is Co-Principal Investigator in a large European consortium on rare neurodegenerative diseases where he overlooks specifically gene panel, exome, and genome sequencing (www.rd-neuromics.eu). Moreover, he is vice president of the German Society of
Chief Financial Officer
Richard joined CENTOGENE April 1, 2016, providing international expertise in global financial topics and leadership in the IPO plans of CENTOGENE. His experience and know-how will support CENTOGENE in its' further global Growth Plans.
With over 25 years of experience in international leadership roles covering the full width of governance and risk concepts, his expertise, combined with his extensive change management skills will ensure that the finance organization will enable the company to continue its expansive growth path.
Richard previously served as Head of Internal Audit at Holcim, a listed multinational company in Switzerland, where he was being asked by the Supervisory- and Executive Board to lead the change of this function from a globally distributed model to a centralized, risk based, model. This change, in the first year, resulted in an increased value add to the business and a huge increase in the awareness of an effective internal control structure.
From1985 to 2013 he was active in different Audit- and
Management-positions at (a.o.) KPMG, in Chicago, Frankfurt, Hong Kong and the Netherlands. During his international Audit tenure he was responsible for Audits of a multitude of small and large (listed on various stock exchanges, including the US) clients in a wide variety of industries, including the Pharma industry. He developed a new entity on Strategic Alliances, where he also provided strategy consulting services, including business planning and related funding. As Partner in Charge of one of the offices he created a values based turn-around. Subsequently he was HR responsible in the Management Team for the audit practice of KPMG NL-south. This role led to a further roll out of his Management Development initiatives in Hong Kong, China and Germany. Furthermore, he was involved in IPO`s and Bond issuances on a variety of stock exchanges. Richard was an active public speaker during his leadership- and business development role of the China Practice, both in Hong Kong-China, and in Europe – where he led the EMA China Practice.
Richard graduated as a Dutch CPA with the NBA and Tilburg University - the Netherlands, with further executive education programs at Harvard Business School, Insead (Executive MBA), IMD and IESE.
Volkmar Weckesser PhD
Chief Information Officer
Volkmar joined CENTOGENE on June 1, 2016, bringing with him broad experience in planning and implementing enterprise
information systems to support both distributed and centralized business operations. His vast skill and know-how will support CENTOGENE in the global development of IT based genetic
software infrastructure and the mutation data base, CentoMD®.
With over 20 years of experience in IT, management of large transformation programs, and process optimization, he will
ensure that IT will be a key driver for the further development of CENTOGENE.
Volkmar previously served as CIO of the Gothaer Insurance
Enterprise and CEO of the incorporated Gothaer Systems GmbH, where he successfully implemented a new IT-strategy, realigned their IT-architecture, and restructured the project portfolio. The IT cost savings program, which he initiated, resulted in a significant reduction of costs of operation.
From 2009 to 2013 Volkmar was Director IT at DekaBank, guiding the modernization of the IT-systems and the establishment of a new IT governance in close collaboration with all parties involved.
Prior to that, he served as Director of IT/Organization at the HSH Nordbank AG and her predecessor for ten years. There he
focused on planning and implementation of the enterprise-wide IT-strategy. He also successfully realized the consolidation of the IT systems (post-merger IT integration) at the HSH Nordbank AG.
Volkmar started his career as a management consultant for the Mitchell Madison Group and Monitor Company.
Volkmar studied techno mathematics at the University of
Karlsruhe and holds a PhD in mathematics.